226 related articles for article (PubMed ID: 20593941)
1. Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients.
Erbey F; Bayram I; Yilmaz S; Tanyeli A
Asian Pac J Cancer Prev; 2010; 11(1):123-6. PubMed ID: 20593941
[TBL] [Abstract][Full Text] [Related]
2. Imipenem in the treatment of febrile neutropenic children.
Erbey F; Bayram I; Yilma S; Tanyeli A
Asian Pac J Cancer Prev; 2009; 10(5):921-4. PubMed ID: 20104991
[TBL] [Abstract][Full Text] [Related]
3. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
Hung KC; Chiu HH; Tseng YC; Wang JH; Lin HC; Tsai FJ; Peng CT
J Microbiol Immunol Infect; 2003 Dec; 36(4):254-9. PubMed ID: 14723254
[TBL] [Abstract][Full Text] [Related]
4. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
5. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
6. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
[TBL] [Abstract][Full Text] [Related]
8. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
Fleischhack G; Hartmann C; Simon A; Wulff B; Havers W; Marklein G; Hasan C; Bode U
J Antimicrob Chemother; 2001 Jun; 47(6):841-53. PubMed ID: 11389117
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
[TBL] [Abstract][Full Text] [Related]
10. [Meropenem therapy in children with febrile neutropenia].
Müller J; Kovács G; Garami M; Schmidt M; Fekete G
Orv Hetil; 2003 Oct; 144(43):2115-20. PubMed ID: 14661443
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of meropenem as an empirical treatment for febrile neutropenia in children with cancer.
Pancharoen C; Mekmullica J; Buranachonapa J; Trongjit D; Nuchprayoon I; Vanichsetakul P; Seksarn P; Thisyakorn U
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S174-8. PubMed ID: 12929986
[TBL] [Abstract][Full Text] [Related]
12. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
Feld R; DePauw B; Berman S; Keating A; Ho W
J Clin Oncol; 2000 Nov; 18(21):3690-8. PubMed ID: 11054442
[TBL] [Abstract][Full Text] [Related]
13. Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
Malik I; Shaharyar
J Pak Med Assoc; 2002 Jan; 52(1):15-8. PubMed ID: 11963577
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
Corapcioglu F; Sarper N; Zengin E
Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
[TBL] [Abstract][Full Text] [Related]
15. Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients.
Vandercam B; Gérain J; Humblet Y; Ferrant A; Wauters G; Moreau M; Longueville J; Symann M; Straetmans N
Ann Hematol; 2000 Mar; 79(3):152-7. PubMed ID: 10803938
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
[TBL] [Abstract][Full Text] [Related]
17. Meropenem in the treatment of febrile neutropenic children.
Müller J; Garami M; Constantin T; Schmidt M; Fekete G; Kovács G
Pediatr Hematol Oncol; 2005 Jun; 22(4):277-84. PubMed ID: 16020114
[TBL] [Abstract][Full Text] [Related]
18. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
Hodgson-Viden H; Grundy PE; Robinson JL
BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
[TBL] [Abstract][Full Text] [Related]
19. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors.
Düzova A; Kutluk T; Kanra G; Büyükpamukçu M; Akyüz C; Seçmeer G; Ceyhan M
Turk J Pediatr; 2001; 43(2):105-9. PubMed ID: 11432485
[TBL] [Abstract][Full Text] [Related]
20. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
de la Cámara R; Figuera A; Sureda A; Hermida G; Verge G; Olalla I; Fernández Rañada JM; Domingo Albos A
Haematologica; 1997; 82(6):668-75. PubMed ID: 9580087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
